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Radiation Biology, Semmelweis University, Budapest, HungaryABSTRACT Cardiac myosin binding protein-C (cMyBP-C) is a member of the immunoglobulin (Ig) superfamily of proteins and
consists of 8 Ig- and 3 fibronectin III (FNIII)-like domains along with a unique regulatory sequence referred to as the MyBP-C
motif or M-domain. We previously used atomic force microscopy to investigate the mechanical properties of murine cMyBP-
C expressed using a baculovirus/insect cell expression system. Here, we investigate whether the mechanical properties of
cMyBP-C are conserved across species by using atomic force microscopy to manipulate recombinant human cMyBP-C and
native cMyBP-C purified from bovine heart. Force versus extension data obtained in velocity-clamp experiments showed that
the mechanical response of the human recombinant protein was remarkably similar to that of the bovine native cMyBP-C. Ig/
Fn-like domain unfolding events occurred in a hierarchical fashion across a threefold range of forces starting at relatively low
forces of ~50 pN and ending with the unfolding of the highest stability domains at ~180 pN. Force-extension traces were also
frequently marked by the appearance of anomalous force drops suggestive of additional mechanical complexity such as struc-
tural coupling among domains. Both recombinant and native cMyBP-C exhibited a prominent segment ~100 nm-long that could
be stretched by forces <50 pN before the unfolding of Ig- and FN-like domains. Combined with our previous observations of
mouse cMyBP-C, these results establish that although the response of cMyBP-C to mechanical load displays a complex pattern,
it is highly conserved across species.INTRODUCTIONMyosin binding protein-C (MyBP-C) is an accessory pro-
tein of muscle sarcomeres (1) that binds tightly to thick
(myosin-containing) filaments and regulates the ability of
myosin to interact with actin to generate force. In the heart,
the cardiac isoform of MyBP-C (cMyBP-C) promotes actin
and myosin interactions in response to inotropic stimuli so
that cMyBP-C is necessary for enhanced cardiac contrac-
tility, for example in response to increased stimulation by
catecholamines (2,3). The importance of cMyBP-C in
cardiac function is further highlighted by the recognition
that mutations in the gene encoding cMyBP-C, MYBPC3,
are among the most frequent causes of inherited hyper-
trophic cardiomyopathy, the leading cause of sudden cardiac
death in young people in the United States and a prominent
cause of heart failure in older adults in diverse geographic
populations across the globe (4,5). cMyBP-C is a member
of the immunoglobulin (Ig) superfamily of proteins being
composed of 11 Ig- or fibronectin (FNIII)-like domains
with each domain numbered consecutively, C0 through
C10, beginning at the N-terminus of the molecule (Fig. 1).
Between neighboring domains there are linker sequences
that vary in length, composition, and structure (6–8). Two
of the longest linkers occur in the N-terminal half of the pro-
tein. One of them is an ~52-amino-acid-long sequence that
is rich in proline and alanine residues (the P/A region) and is
located between domains C0 and C1. The second is anSubmitted November 30, 2012, and accepted for publication April 8, 2013.
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0006-3495/13/06/2465/11 $2.00~105-residue-long linker called the M-domain that is
located between the C1 and C2 domains. The M-domain
constitutes a central regulatory motif of cMyBP-C with
phosphorylation sites unique to the cardiac isoform of
MyBP-C located within this region. Phosphorylation of
these sites by a number of kinase reduces the ability
of cMyBP-C to bind to actin (9,10) or myosin S2 (11).
Domains C8–C10 at the C-terminus of the molecule bind
to titin and the light meromyosin segment of myosin and
are responsible for anchoring cMyBP-C to the thick filament
backbone (12–14).
Additional insights into the structure of cMyBP-C were
recently obtained in studies using NMR (8) and single-
molecule atomic force microscopy (AFM) (15). In these
studies the M-domain was shown to be partially folded
and to contain intrinsically disordered sequences, whereas
the P/A-rich region was predicted to be entirely disordered
(15,16). Furthermore, the Ig- and FNIII-like domains of
recombinant mouse cMyBP-C were found to be mechani-
cally weaker than those of other Ig/FnIII proteins such as
titin (17–19). cMyBP-C is thus suggested to be highly
extensible under low loads, potentially making it well suited
to function as a sarcomeric mechanosensor (20,21) or as a
compliant spring-like element such as the PEVK segment
of titin (22,23). Ultimately, order-disorder transitions modu-
lated by mechanical stress, phosphorylation, or ligand bind-
ing may provide a basis for dynamic regulation of cMyBP-C
structure and function during contraction.
The purpose of the current experiments was to investigate
whether the general mechanical features of cMyBP-C firsthttp://dx.doi.org/10.1016/j.bpj.2013.04.027
FIGURE 1 Schematic diagrams showing the
domain structure of cMyBP-C and an AFM exper-
iment. (A) Domain organization of cMyBP-C
showing that cMyBP-C is a multidomain protein
consisting of 11 Ig- (circles) or FNIII-like domains
(squares) numbered C0–C10. Sequences linking
the Ig/FNIII-like domains include a sequence rich
in prolines and alanines (the P/A region) located
between domains C0 and C1 and the regulatory
M-domain (M) located between domains C1 and
C2. Phosphorylation sites (P) within the M-domain
are indicated. Binding sites to myosin S2 and to
actin are indicated by black lines near the
N-terminus of cMyBP-C. Binding sites to light
meromyosin and titin are indicated by black lines
near the C-terminus. (B) Coomassie stained SDS-
PAGE of recombinant human cMyBP-C and
purified native bovine cMyBP-C showing pro-
tein purity. (C) Schematic diagram showing
mechanical load imposed on a single cMyBP-C
molecule with an AFM cantilever.
2466 Karsai et al.identified in murine cMyBP-C are conserved across species
and whether native and recombinant cMyBP-C molecules
exhibit similar mechanical properties. In our previous study,
we investigated the mechanical responses of mouse
cMyBP-C expressed in a baculovirus/insect cell expression
system (15). Here, we extended these studies by investi-
gating the mechanical properties of recombinant human
cMyBP-C expressed in a baculovirus/insect cell system
and native cMyBP-C purified from bovine heart. The results
show that the mechanical responses of cMyBP-C are
remarkably similar across species and that native and
recombinant cMyBP-C molecules display comparable
properties under load. Taken together, our results establish
a common mechanical fingerprint of cMyBP-C that includes
hierarchical unfolding of Ig/FNIII-like domains over a range
of relatively low forces (<180 pN), and the extension of
compliant regions including the regulatory M-domain at
forces below 50 pN.METHODS
Protein expression and purification
A full-length human cMyBP-C cDNA was obtained by reverse transcrip-
tion polymerase chain reaction, from human cardiac total RNA (Strata-
gene, La Jolla, CA). The cDNA (GenBank accession no. NM_000256.3)
was subcloned and used for protein expression as previously described
for the murine protein (15). Protein purity typically exceeded 95% as
assessed with sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS PAGE) (8% gel) (Fig. 1 B, left). Proteins were used within 1 week
of preparation.
Native cMyBP-C (GenBank accession no. NP_001070004) was purified
from bovine heart according to Hartzell and Glass (24) with modificationsBiophysical Journal 104(11) 2465–2475as described below. Hearts were obtained from cows freshly slaughtered at
the UC Davis Department of Animal Science Meat Lab. Left ventricles
were removed from the hearts, dissected free of connective tissue and
fat, and ground before freezing in liquid nitrogen and stored at 80C
until further use. Throughout the purification all samples were kept on
ice or at 4C. Briefly, 65 g of fresh or thawed tissue was homogenized
in a blender for 2 min. The homogenate was washed 5 in 300 ml of
Buffer A containing (in mM) 50 KCl, 20 Tris-HCl, 2 EDTA, 15
2-mercaptoethanol, pH 7.9 in successive cycles of centrifugation
(3000  g, 15 min) and resuspension. After each centrifugation the pellet
was homogenized with a Polytron homogenizer. Homogenization steps
were repeated two more times using 300 ml Buffer A containing 1%
Triton-X, and then five times using 300 ml Buffer A (without Triton) until
the pellet became white. The pellet was then resuspended in 150 ml
EDTA-PO4 buffer containing (in mM) 10 EDTA, 124 NaH2PO4, 31
Na2HPO4 pH 5.9, and stirred for 15 min. The solution was then centri-
fuged (10,000  g, 20 min) and the supernatant retained. The EDTA
extraction was repeated once on the pellet, and the two supernatants
were pooled. cMyBP-C was precipitated from the pooled supernatants
by slowly adding saturated ammonium sulfate to a 45% final concentra-
tion. Precipitated cMyBP-C was collected by centrifugation (15,000 
g, 15 min). The pellet was dissolved in 8 ml Buffer K containing
(in mM) 300 KCl, 5.2 K2HPO4, 4.8 NaH2PO4, 2 NaN3, 0.1 EDTA, 3
2-Mercaptoethanol pH 5.9 and dialyzed against Buffer K overnight. The
extract containing cMyBP-C protein was then chromatographed on a
2.5  35-cm column of hydroxylapatite and eluted with a pH 6.8
phosphate gradient from (in mM) 300 NaCl, 2 NaN3, 0.1 EDTA, 3 2-mer-
captoethanol, 15 NaH2PO4, 28 K2HPO4 to 300 NaCl, 1 NaN3, 0.1 EDTA,
3 2-mercaptoethanol, 56 NaH2PO4, 119 K2HPO4. The purest fractions
were pooled for experiments and used within 1 week. The purity of bovine
cMyBP-C was assessed with SDS PAGE (8% gel) (Fig. 1. B, right).AFM
AFM measurements, data inclusion criteria, and analysis procedures were
performed as previously described (15). Data were obtained using an
MFP3D instrument (Asylum Research, Santa Barbara, CA) housed at the
Conserved Mechanical Properties of cMyBP-C 2467UC Davis Spectral Imaging Facility. BioLever A cantilevers (silicon nitride
probe, gold coated, Olympus, Tokyo, Japan) were used to obtain force
measurements and the stiffness (k) of each cantilever was calculated by
measuring the thermally driven mean-square vertical bending fluctuations
and applying the equipartition theorem (25). Typical cantilever stiffness
was ~30 pN/nm.
Immediately before the AFM experiments, proteins were clarified by
ultracentrifugation at 400,000  g for 30 min and diluted to 20–25 mg/
ml in a buffer containing (in mmol/L) 20 imidazole, 180 KCl, 1 MgCl2,
1 EGTA, 1 DTT, pH 7.4. Diluted proteins (in ~100 ml volumes) were
deposited by nonspecific adsorption onto cleaned glass slides. Unbound
cMyBP-C was washed away after 1 min by gently rinsing the slide 5
with fresh buffer (~150 ml). Force versus extension curves were then
collected by pressing the cantilever tip into the protein-coated surface
and raising the cantilever tip up to 600 nm above the glass surface with
a constant pulling speed (100, 500, 3000, or 5000 nm/s) to stretch a
cMyBP-C molecule adhered to the cantilever tip. The experimental
arrangement is shown in Fig. 1 C. Displacement of the cantilever base
was measured by using an integrated linear voltage differential trans-
former. Force (F) was obtained from cantilever bending (d) according
to the formula of stiffness (F ¼ dk). Force-displacement curves were cor-
rected as described previously (15). Contour length (Lc) and persistence
length (Lp) values were obtained by fitting the continuous, nonlinear parts
of the force traces with the worm-like chain (WLC) equation (26) using
the built-in software of the Asylum AFM Instrument (Igor Pro 6.0 Wave-
Metrics, Portland, OR, MFP version 090909, Asylum Research, Santa
Barbara, CA.).Monte Carlo simulations
Force-driven cMyBP-C unfolding was simulated using an elastically
coupled two-state model (27,28) in which the activation kinetics are
influenced by the mechanical load and the shape of the unfolding
potential. In the simulation a full-length cMyBP-C molecule is pulled
at a constant, preadjusted velocity. The initial contour length of the
molecule was set according to the number of Ig/FNIII globular domains
(11  4 nm) and the theoretical total lengths of the unstructured regions
(108, 115, and 120 nm for the human, bovine, and mouse proteins,
respectively). As the chain was extended, force was generated according
to the WLC equation (29). In each polling interval (dt) the probability
(Pu) of domain unfolding at the given force (f) was calculated
according to
Pu ¼ u0 dteðEaufDxuÞ=kBT ; (1)
where u0 is attempt frequency set by Brownian dynamics (30), kBT is
thermal energy, Eau is activation energy of unfolding, and Dxu is distance
between the folded and transition states along the unfolding reaction coor-
dinate. Domain unfolding was permitted or prohibited depending on a com-
parison of P with a number generated randomly between 0 and 1. Each
domain unfolding event incremented the molecule’s contour length by
34.2, 33.4, and 33.2 nm, which are the average unfolded protein chain
lengths of the component globular domains of human, bovine, and mouse
cMyBP-C, respectively. To obtain the unfolding potential width (Dx) and
the unfolding activation energy (Ea) for the average globular domain of
different types of cMyBP-C, iterative simulation cycles were carried out
in which each of the parameters were independently changed with incre-
ments of 0.005 nm and 5  1022 J, respectively. The unfolding forces
obtained during stretch-velocity-dependent simulations were then com-
pared with the experimental data set.Statistics
All values represent mean 5 SD.RESULTS
Force-extension curves of recombinant and
native cMyBP-C
The mechanical properties of individual human and bovine
cMyBP-C molecules were investigated using single-
molecule AFM. Fig. 1 C shows a schematic of the exper-
iments: cMyBP-C molecules were first adsorbed onto a
glass surface, and then picked at random attachment points
along their contour and stretched by moving the cantilever
away from the slide surface. The molecules became
stretched until the load on the molecule was sufficient to
mechanically unfold tertiary and secondary structures
such as the b-pleated sheets of Ig-like domains. Domain
unfolding events were evident as characteristic sawtooth
peaks in the force-extension traces caused by the sudden
drop of cantilever force as each domain unfolded causing
an incremental increase in the overall molecular contour
length (DL) (31). The height of the individual peaks marks
the force in the instant of domain unfolding and depends
on the mechanical stability of the domains and the
loading rate. The greater the mechanical stability or the
loading rate, the greater the instantaneous force and vice
versa (32).
A total of 51 force-extension curves for human recom-
binant cMyBP-C were obtained at stretch rates ranging
between 200 and 5000 nm/s. As shown in Fig. 2 A for a
force-extension curve of a full-length human cMyBP-C
molecule, the maximum number of peaks in any one spec-
trum was 11 (with the final, 12th peak corresponding to
the detachment of the molecule from the cantilever tip or
the slide surface), as predicted for the total combined num-
ber of Ig- and FNIII-like domains within a single cMyBP-C
(6). In two spectra with 11 peaks the maximum measured
contour lengths (Lc) were 452 and 490 nm, both in re-
asonable agreement with the theoretical predicted Lc of
492 nm (0.38 nm/amino acid (aa)  1295) for a full-length
molecule. Notably, the recombinant human cMyBP-C used
in our experiments contained 1295 residues including a
21-aa-long His-tag and short linker sequence appended at
the N-terminus to aid in protein purification. Fig. 2 B shows
a single-molecule force-extension curve for cMyBP-C
purified from bovine heart. Human and bovine cMyBP-C
display ~89% sequence identity (Fig. S1 in the Supporting
Material), and the gross structural arrangement of their
Ig- and FNIII-like domains is similar, with 11 Ig/FNIII
domains predicted for both. Consistent with this, the
force-extension relationships obtained from native bovine
cMyBP-C appeared very similar to those obtained from
recombinant human cMyBP-C. The length of bovine
cMyBP-C is predicted to be 1269 aa, yielding a maximum
theoretical Lc of 482 nm (0.38 nm/aa  1269 aa). A single
force versus extension curve with 11 unfolding peaks was
obtained with a contour length of 454 nm (Fig. 2 B).Biophysical Journal 104(11) 2465–2475
FIGURE 2 Representative force-extension curves and summary unfold-
ing data for human and bovine cMyBP-C. Force-extension curves obtained
from (A) recombinant human cMyBP-C and (B) native bovine cMyBP-C
obtained at pulling speeds of 3000 and 5000 nm/s, respectively. Stretching
individual cMyBP-C molecules resulted in a pattern of sawtooth peaks
indicative of Ig/FNIII domain unfolding. Black lines indicate WLC model
fits to the data. (C) Plots of unfolding force versus peak position (peak
number) for human cMyBP-C (gray circles) and purified native bovine
cMyBP-C (black squares).
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2468 Karsai et al.Fig. 2 C shows summary data for the average forces
required to unfold individual domains of human and bovine
cMyBP-C plotted against the order of each unfolding event
in a force curve. The Ig/FNIII domains of both human and
bovine cMyBP-C unfolded at gradually increasing forces
across a force range of ~50 to 180 pN similar to our previous
results on mouse recombinant cMyBP-C (15). The three- to
fourfold difference in forces required to unfold the first
versus the final domains suggests that the different domains
of cMyBP-C exhibit a wide range of mechanical stabilities.
The average unfolding force of all domains of human
cMyBP-C was 97.6 5 31.6 pN at a pulling speed of
3000 nm/s; the average unfolding force for all bovine do-
mains was 94.15 28.8 pN at pulling speeds of 5000 nm/s.
The WLC model (26) was used to calculate the DL that
resulted from each domain unfolding event. The average
DL for the unfolding of all individual domains of human
cMyBP-C was 32.35 11.8 nm (n ¼ 340). When corrected
for the folded length of the domains (~4 nm) this value
agrees well with the average theoretical contour lengths of
the domains that are predicted to be 34.2 5 8.7 nm using
domain boundaries as determined by DomPred (33) and
PONDR (34) (see Fig. S6). A histogram showing the dis-
tribution of domain contour lengths from 51 human force-
extension curves with 5–11 sawtooth peaks is shown in
Fig. S2. For bovine cMyBP-C the average DL per unfolded
domains was 31.75 11.3 nm (n ¼ 171) (Fig. S2), which is
also in reasonable agreement after correction for domain
folding with the average theoretical domain contour lengths
of the bovine domains (33.4 5 8.9 nm) (33,34).Mechanical complexity in Ig/FnIII unfolding
Fig. 3 shows several force-extension curves obtained from
recombinant human and native bovine cMyBP-C. Promi-
nent features observed in many of the force-extension plots
are instances where the force required to unfold an Ig/
FNIII-like domain was anomalously lower than the force
required to unfold the preceding domain (arrowheads).
Similar drops in force were also observed in force-exten-
sion plots of mouse cMyBP-C (15), but the occurrence
of the force drop events in human cMyBP-C were more
stereotyped than in the mouse force-extension curves.
For example, Fig. 3 A shows three independent force
curves containing 8, 9, or 10 unfolding events that were
superimposed to reveal a force drop that appeared at an
identical location in each of the curves. A force drop
was also observed in a full-length force curve representing
a completely unfolded human cMyBP-C (Fig. 3 B). The
difference in force between the preceding peak and the
dropped peak was up to 50 pN (Fig. S3); this exceeds
the standard error of the average domain unfolding force
and particularly the error of the position-normalized
domain unfolding force (see Fig. 2 C). In a homogenous
system, such as a homopolymer, mechanically driven
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FIGURE 3 Force-extension curves showing anomalous force drops. (A)
Three force versus extension curves obtained from human cMyBP-C in
three independent experiments are shown superimposed. Each curve shows
a distinct force drop at the 6th unfolding peak (gray arrow). (B) A
full-length force-extension curve of a human cMyBP-C molecule. Gray
arrow indicates a force drop at the 5th unfolding peak. (C) Example force
versus extension curves for human (a and b) and bovine (c and d)
cMyBP-C. Gray arrows indicate force drops at various locations.
Conserved Mechanical Properties of cMyBP-C 2469unfolding at a constant loading rate occurs at a similar,
average force for each component domain (35). However,
in a heterogeneous system such as the cMyBP-C molecule,
the unfolding of mechanically unstable domains precedes
that of the stable ones, which unfold at progressively
increasing instantaneous forces (17). Thus, in a serially
linked system of interaction free domains mechanically
driven unfolding follows an order set by the relative
mechanical stabilities of the individual domains, resulting
in a sawtooth-shaped force spectrum with gradually
increasing force peaks. A large force drop is therefore un-expected, and its systematic presence likely points at
structural coupling within the chain.
Force drops were also evident in force-extension plots
from native bovine cMyBP-C (Fig. 3), although their
position was not as systematic as for human cMyBP-C. In
this respect, the frequency and positions of force drops for
bovine cMyBP-C were more similar to those reported
previously for mouse recombinant cMyBP-C (15). Force
drops >15 pN were observed in 17 out of 35 bovine force
spectra and 21 out of 51 human force spectra.Pulling rate dependence of unfolding forces and
mechanical stability of different domains
To further investigate possible differences between recom-
binant human and native bovine cMyBP-C molecules, the
pulling rate dependence of domain unfolding events was
measured. Fig. 4 shows histogram distributions of domain
unfolding forces for human and bovine cMyBP-C Ig/FNIII
domains at pulling rates of 500, 3000, and 5000 nm/s.
Fig. 4 A (inset) shows a histogram of unfolding force for
human cMyBP-C measured at 200 nm/s pulling rate. For
both human and bovine cMyBP-C the mean unfolding force
and the width of the unfolding force distribution increased
as expected with increased pulling rate (17,18,32). The
mean unfolding forces for recombinant human cMyBP-C
were 77.9 5 27 pN, 97.6 5 31.6 pN, and 103.3 5
32.5 pN at pulling rates of 500, 3000, and 5000 nm/s,
respectively. The mean unfolding forces for native bovine
cMyBP-C were 74.5 5 17.2 pN, 89.2 5 28.2 pN, and
94.8 5 28.3 pN at pulling rates of 500, 3000, and
5000 nm/s, respectively.
Fig. 5 shows a cross-species comparison of the average
unfolding forces for human, mouse, and bovine cMyBP-C
plotted against pulling rate. Data for the recombinant mouse
cMyBP-C were reprinted from (15) and are included here to
facilitate comparisons. Notably, all cMyBP-C molecules
exhibited similar mechanical stabilities at loading rates of
500, 3000, and 5000 nm/s, but bovine and human cMyBP-C
showed a weak trend for lower mechanical stability relative
to mouse cMyBP-C at the highest pulling speeds. The slopes
of the human and bovine relationships were also similar and
slightly less steep than the mouse relationship. Differences
between human and bovine cMyBP-C were not significant
at any pulling speed.Monte Carlo simulations of mechanically driven
cMyBP-C unfolding
To reveal the equilibrium unfolding activation kinetics and
characterize the shape of the unfolding potentials, Monte
Carlo simulations (Fig. S4) were carried out and compared
with experimental data. Fig. 5 shows results from the Monte
Carlo simulations (straight lines) superimposed over the
experimental data of mean unfolding forces obtained atBiophysical Journal 104(11) 2465–2475
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FIGURE 4 Pulling rate dependence of unfolding forces for human and
bovine cMyBP-C. Unfolding-force distributions of cMyBP-C from human
(gray bars) and bovine (black contours) are shown at pulling rates of (A)
500 nm/s, (B) 3000 nm/s, and (C) 5000 nm/s. Inset in A shows unfolding
force of human cMyBP-C at 200 nm/s pulling rate.
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FIGURE 5 Cross-species comparisons of pulling rate dependence of
mean unfolding forces for cMyBP-C Ig/FNIII domains. The pulling speed
dependence for the average unfolding forces of recombinant human and
native bovine cMyBP-C are shown plotted at various pulling speeds
and compared to recombinant mouse cMyBP-C. Data for recombinant
mouse cMyBP-C were replotted from (15) to facilitate comparisons with
human and bovine cMyBP-C. Solid and dashed lines are Monte Carlo
simulation fits for human, bovine, and mouse cMyBP-C shown superim-
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FIGURE 6 Unfolding potential diagrams from Monte Carlo simulations.
Potential diagrams were drawn using activation energy (DG0) and unfold-
ing potential width (Dx) parameters obtained fromMonte Carlo simulations
for the three different (human, bovine, and mouse) cMyBP-C proteins.
2470 Karsai et al.pulling rates of 500, 3000, and 5000 nm/s (mouse data from
(15)). Best fits to the data were obtained with activation en-
ergy and unfolding potential width values of 16.4 kcal/mol
and 0.53 nm, 15.53 kcal/mol and 0.42 nm, and 14.7 kcal/mol
and 0.315 nm for bovine, human, and mouse cMyBP-C,
respectively (see Table 2). Fig. 6 summarizes the data by
displaying the unfolding potentials for the three cMyBP-C
orthologs. Notably, the greater the activation barrier, the
greater the width of the unfolding potential and vice versa.
Thus, although bovine cMyBP-C is thermodynamically
the most stable among the different cMyBP-C molecules,
because of the shape of its unfolding potential, it will unfold
most easily at pulling rates exceeding 100 nm/s. Conversely,
although the mouse cMyBP-C is the least thermodynami-
cally stable, because of the shape of its unfolding potential,Biophysical Journal 104(11) 2465–2475at pulling rates exceeding 100 nm/s it will display the
greatest mechanical stability among the three proteins.
Conceivably, tuning the unfolding potential width could
function as an adaptive mechanism to reinforce mechanical
stability at high pulling rates.Extensibility of cMyBP-C at low forces
A characteristic feature of force-extension curves deter-
mined previously from recombinant mouse cMyBP-C was
AB
C
FIGURE 7 Low-compliance extensible segments of human cMyBP-C.
(A) Two representative force versus extension curves for human cMyBP-C
showing variable lengths of the initial extensible segments. WLC fits to the
extensible segments are shown in gray. (B) Histogram of the contour length
distribution of the extensible regions of human (dashed bars) (129.2 5
25.8 nm, n ¼ 35) and bovine cMyBP-C (gray bars) (105.1 5 23.4 nm,
n ¼ 18). (C) Histogram of the persistence length distribution of human
Conserved Mechanical Properties of cMyBP-C 2471the presence of a variable length (Lc ¼ 137.4 5 25 nm)
extensible segment located at the beginning of the force-
extension traces (15). The segment was evident as a gradual
rise in force up to ~50 pN before Ig/FNIII domain unfolding
events that were seen as regularly spaced sawtooth peaks.
For a force-extension curve obtained from a fully unfolded
cMyBP-C molecule, the length of this initial feature pre-
sumably includes the contour length of the fully straight-
ened cMyBP-C molecule (e.g., for a full-length molecule
this could be z44 nm ¼ 11 domains  4 nm/domain)
and extension of the mechanically weakest segment(s) of
the protein such as unstructured or instrinsically disordered
linker sequences or segments with secondary structure that
are not otherwise folded into stable tertiary structures. For
mouse cMyBP-C, we showed that the M-domain con-
tributed to the extensible segment of the force-extension
spectra (15) in good agreement with NMR data (8), which
demonstrated the M-domain consists of disordered
sequences along with three a-helices arranged in a compact
bundle.
Fig. 7 shows the initial extensible segments from two
recombinant human cMyBP-C molecules and summary
data of Lc and Lp values obtained from WLC fits of the
initial portions of human and bovine cMyBP-C force-exten-
sion curves. Similar to the mouse data (15), the histogram of
contour lengths for the extensible segments of human
cMyBP-C (Fig. 7 B) showed a broad distribution of lengths
from 71–186 nm with an average Lc of 129.2 5 25.8 nm
(from 35 spectra with an average number of 7 peaks). The
Lp values for the human cMyBP-C also showed a broad
variation from 0.33 to 2.6 nm with an average of 0.83 5
0.51 (n ¼ 35). For bovine cMyBP-C the Lc distribution of
the extensible region featured a single Gaussian distribution
between 75 and 173 nm with an average Lc of 105.1 5
23.4 nm (Fig. 7 B). The average Lp of bovine cMyBP-C
was 0.79 5 0.51 nm (n ¼ 18 spectra with an average of 7
peaks) and ranged from 0.21 to 1.85 nm (Fig. 7 C). The
broad distribution observed for both the contour lengths
and persistence lengths likely reflects variations in the site
of cantilever attachment in different cMyBP-C molecules
and is consistent with the idea that multiple linker segments
with variable lengths and secondary structures contribute to
responses of cMyBP-C to stretch under load as for titin’s
PEVK region (37).(dashed bars) (0.835 0.51 nm, n ¼ 35) and bovine (gray bars) (0.79 5
0.51 nm, n ¼ 18) cMyBP-C.DISCUSSION
We recently determined the characteristic mechanical prop-
erties of individual cMyBP-C molecules by using AFM on
proteins expressed from a mouse cMyBP-C cDNA (15). In
this study we extended these experiments to include orthol-
ogous cMyBP-C molecules from different species using
proteins obtained from both native and recombinant
sources. The main conclusion from this study is that the
overall mechanical response of individual cMyBP-C mole-cules is complex, representing multiple distinct contribu-
tions from both compliant and stably folded sequences,
however the mechanical signature of cMyBP-C is highly
conserved across species from mouse to human. Collec-
tively, our results thus establish a characteristic mechanical
fingerprint common to cardiac MyBP-C molecules. The
common features of cMyBP-C from the different sources
include a pronounced, overall highly hierarchical unfoldingBiophysical Journal 104(11) 2465–2475
2472 Karsai et al.of Ig and FNIII domains, a systematic pattern of unfolding
events including stereotyped events that are suggestive of
structural coupling between domains, and the presence of
multiple elastic segments that together can be extended to
lengths exceeding 100 nm by forces smaller than ~50 pN.
These low-force extensible segments probably include
sequences with little or no tertiary structure such as intrinsi-
cally disordered sequences and partially folded helices
(8,38–40) such as those occurring in the M-domain. Details
revealed by dynamic force spectroscopy suggest that the
different domain stabilities of cMyBP-C can provide an
adaptive mechanism that aids in avoiding extensive domain
unfolding at high loading rates.Conserved mechanical features of cMyBP-C
The finding that the general mechanical features of
cMyBP-C are conserved across different species is consis-
tent with the high degree of sequence similarity (~89%
identity) of bovine and mouse cMyBP-C sequences
compared to human cMyBP-C (Fig. S1). The high degree
of sequence identity includes the Ig/FNIII domains that
typically share >90% identity suggesting that there is a
strong selection pressure to maintain the physical properties
and functions of the individual Ig/FNIII domains at each
unique position along the length of a cMyBP-C molecule.
This high degree of sequence conservation is especially
striking given that relatively few amino acids are necessary
for the determination of the overall mechanical stability of
an Ig b-fold (41). By comparison, neighboring Ig/FnIII
domains within a single cMyBP-C molecule are far less
conserved with the most similar domains being ~33% iden-
tical (Fig. S1 B). The lack of similarity between adjacent
domains most likely underlies the mechanical heterogeneity
observed leading to the wide range of stabilities of the
different domains within a single cMyBP-C molecule
(Fig. 2 C). An analogous lack of sequence similarity was
also noted among the Ig domains of titin’s I-band that also
display a mechanical unfolding hierarchy and that could
be grouped into strong and weak families (41,42). By
comparison to these domains, all of the cMyBP-C un-
folding events belong to the weak category (unfolding at
loads <200 pN) making them more similar to actin cross-
linking proteins such as filamin A (43) rather than the
mechanically strong Ig domains of titin or myomesin
(17,39,44,45).
In comparing the overall stabilities of Ig/FNIII domains
across the different species (Fig. 5), there was a weak trend
that the mouse domains unfolded at higher forces than either
the human or bovine domains, although the differences were
not statistically significant. However, results from Monte
Carlo simulations (Fig. 6 and Fig. S4), indicated that the
order of stability was reversed among the species-specific
cMyBP-C orthologs under conditions of zero load. That
is, the order of thermodynamic stability when F ¼ 0 wasBiophysical Journal 104(11) 2465–2475bovine > human > mouse, whereas under dynamic loading
conditions (>100 nm/s) it reversed to mouse > human >
bovine. The phenomenon is attributed to the shape of the
unfolding potential (Fig. 6), according to which the width
of the unfolding potential is smallest for the mouse and
largest for the bovine cMyBP-C (see Table 2). Although
under unloaded conditions (F ¼ 0) only the height of the
activation barrier determines the spontaneous domain
unfolding rate, under dynamic loading conditions the shape
of the unfolding potential also strongly influences the
process such that the smaller the width of the unfolding
potential, the greater the loading-rate dependence of un-
folding forces and vice versa. In the beating heart if
cMyBP-C molecules are attached to the thick and thin
filaments at the same time (46,47), they are then exposed
to dynamic loading conditions. It is an intriguing question
whether domain unfolding could occur under the in situ
loading conditions. Considering the physiological cardiac
sarcomere length range (1.6–2.2 mm (48)) and species-
specific heart rates (average 540, 80, and 60 beats per min-
ute in mouse, human, and bovine heart, respectively (49),)
we obtain pulling rates of ~5500, ~800, and ~600 nm/s for
mouse, human, and bovine sarcomeres, respectively. At
these loading rates, unless high instantaneous forces
(>80 pN) are reached, the domains of cMyBP-C are likely
to resist mechanical unfolding in all of the species
investigated.
Another common feature revealed by our cross-species
study was the frequent appearance of force drops in
cMyBP-C force-extension plots (Fig. 3). The occurrence
of low-force peaks interspersed between high-force
sawtooth peaks was previously described in force spectra
of Dictyostelium filamin molecules (43). In that study, the
reduced force peaks were attributed to a stable unfolding
intermediate in one of the Ig domains that resulted in a
two-step unfolding profile. Considering that these two-step
unfolding events resulted in partial contour-length gains
(less than the DL expected for a complete Ig/FNIII domain),
whereas the sawtooth peak spacing was uniform in our
measurements (Fig. S5), it is unlikely that the force drops
observed during the mechanical unfolding of cMyBP-C
molecules were caused by partial domain unfolding
intermediates. Rather, a structural circumstance, such as
coupling between domains, could impose a determinant
order on the sequence of domain unfolding events. In the
case of cMyBP-C there is indeed evidence for associations
among the different Ig domains (e.g., C5 and C8) (50),
and cMyBP-C appears U or V shaped in electron micro-
scope images (51,52) suggesting that additional structural
coupling or stable geometries may be present between
domains.
A long extensible segment with variable length and
morphology was another prominent feature of all cMyBP-C
force-extension curves. The segment typically occupied
~16–20% of the total molecular Lc and was apparent before
Conserved Mechanical Properties of cMyBP-C 2473the appearance of the more regular sawtooth peaks indica-
tive of Ig/FNIII domain unfolding events. The contour
lengths of the human and bovine extensible segments
were not significantly different, but the measured length
of the bovine segment appeared slightly shorter than the
human (105.1 5 23.4 vs. 129.2 5 25.8 nm, respectively).
The difference may reflect the additional length of the
His-tag linker sequence at the N-terminus of the recombi-
nant human cMyBP-C. Consistent with this possibility,
the Lc of the extensible segment of mouse cMyBP-C
(137.4 5 25 nm), which also includes an expressed
N-terminal His-tag, was similar to that of the human
cMyBP-C (15). The persistence lengths (Lp) of the exten-
sible segments were similar in cMyBP-C molecules from
the different species (Tables 1 and 2).
The sequences that contribute to the low-force extensible
segment of cMyBP-C most likely include ones that link the
Ig/FNIII domains together, such as the sequence rich in
proline and alanine residues located between C0 and C1
(~52 aa), the regulatory M-domain that links C1 and C2
(~105 aa), and other shorter sequences between each Ig/
FNIII domain. Computational algorithms predict that
many of these linker segments lack significant secondary
or tertiary structure and have a propensity for intrinsic dis-
order (Fig. S6). For instance, the proline-alanine sequences
of all three cMyBP-C isoforms are predicted to be almost
entirely disordered. This sequence is also the least
conserved of the different isoforms studied (~46% identity).
We previously noted that sequence differences in this region
contribute to an inverse relationship between the percentage
of proline and alanine residues in the segment and the heart
rate in mammals, suggesting that the proline-alanine
segment could potentially contribute to fine-tuning of the
contractile apparatus (53). Although the AFM results pre-
sented here did not reveal systematic differences in the
mechanical properties of the extensible segments of species
with different heart rates (e.g., mouse and human), it is
possible that changes in its mechanical properties would
not be detected because the P/A region accounts for only
~20 nm (52 aa 0.38 nm/aa) of the total length of the exten-
sible segment.
The M-domain is another sequence that is predicted to be
only partially ordered, thereby contributing to the low-force
extensible segment of cMyBP-C force-extension curves
(15). We previously showed using AFM that the M-domainTABLE 1 Summary data of mechanical properties of human, bovin
Huma
Extensible region Lc (nm) 129.215
Lp (nm) 0.835
Ig/FnIII domains Lc (nm) 32.35 11
Unfolding force at different pulling speed (pN) 500 nm/s 77.9 5
3000 nm/s 97.65
5000 nm/s 103.35
Data for mouse cMyBP-C was reprinted from (15). Abbreviations: Lc, contourof a mouse recombinant cMyBP-C exhibited nonlinear
elastic behavior and concluded that, in contrast to earlier
predictions based on small-angle x-ray scattering data
(54), it fails to fold into a stable Ig-like configuration. In
support of the AFM data, recent NMR data also showed
that the M-domain consists of an unstructured sequence
at its N-terminus, which includes the phosphorylatable
serines followed by a more structured region that is folded
into a bundle of three a-helices (8). The trihelix bundle
contains a consensus sequence for actin binding (8) and
has recently been shown to bind calmodulin in the pre-
sence of calcium (55). Because the M-domain is extensible
at low forces, it is an intriguing possibility that modulation
of ligand binding could occur via a mechanical opening
or extension of the trihelix bundle under conditions of
load thereby exposing cryptic binding sites within the
trihelix motif. Furthermore, because phosphorylation often
induces disorder-to-order transitions (or vice versa)
(56,57), phosphorylation could alter the mechanical pro-
perties of the M-domain and potentially affect the stability
of the trihelix bundle (58). If so, then at least some of the
variability observed in the Lp and Lc values of the extensible
segments of the force-extension spectra may be due to
heterogeneity in the phosphorylation states of native and
recombinant proteins (59,60).Physiological significance
This study used AFM to determine the single-molecule
mechanical properties of cMyBP-C from different species
using native and genetically expressed proteins. Together
with previous results from recombinant mouse cMyBP-C
(15), this study establishes a common mechanical finger-
print for cMyBP-C that is well conserved across multiple
species. Although the precise arrangement of cMyBP-C
within the sarcomere is not yet known, there is accumulating
evidence that cMyBP-C spans the interfilament space be-
tween thick and thin filaments (46) and that it interacts
with actin through multiple binding sites in its N-terminal
domains (9,46,61–65). If so, then the mechanical stability
of cMyBP-C may be important in fine-tuning the dynamics
of the interaction between these filamentous systems in sar-
comeres (23). Furthermore, the presence of low-force exten-
sible segments within cMyBP-C may provide a mechanism
for chemically modulated elastic coupling between thee, and mouse cMyBP-C
n cMyBP-C Bovine cMyBP-C Mouse cMyBP-C
25.8 (n ¼ 35) 105.l523 3 (n ¼ 18) 137.45 25 (n ¼ 17)
0.51 (n ¼ 35) 0.795 0.51 (n ¼ 18) 0.655 031 (n ¼ 17)
.8 nm (n ¼ 320) 31.75 11.3 (n ¼ 214) 33.35 15.4 (n ¼ 155)
27 (n ¼ 79) 74.55 17.2 (n ¼ 49) 83.25 30 (n ¼ 149)
31.6 (n ¼ 138) 89.25 28.2 (n ¼ 87) 106.75 31.5 (n ¼ 26)
32.5 (n ¼ 96) 94.85 28.3 (n ¼ 93) 117.55 39.3 (n ¼ 79)
length; Lp, persistence length.
Biophysical Journal 104(11) 2465–2475
TABLE 2 Kinetic parameters obtained from Monte Carlo
simulations
Kinetic
parameters
Human
cMyBP-C
Bovine
cMyBP-C
Mouse
cMyBP-C
Monte Carlo
simulation
DG (kcal/mol) 15.53 16.4 14.7
Dx (nm) 0.42 0.53 0.315
DG is the calculated free energy barrier between the folded and unfolded
state at zero force, Dx is the distance between the folded state and the
transition state along the unfolding reaction coordinate (i.e., width of the
unfolding potential).
2474 Karsai et al.contractile filaments that can respond to the temporally and
spatially localized demands during a single heart beat.SUPPORTING MATERIAL
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